News
Diagnosis of VZV reactivation in CSF was confirmed in 38 patients based on either a positive VZV PCR test in CSF (n=13) or elevated intrathecal anti‐VZV IgG antibody synthesis (n=25). An additional 3 ...
18d
The List on MSNAll Of Justin Bieber's Health Problems ExplainedJustin Bieber has had some very public struggles in recent years, and several of them have involved issues with his physical and mental health.
11h
Smithsonian Magazine on MSNDoctors Detected a Mysterious Antibody in a French Woman’s Body. It Turned Out to Be a Brand New Blood TypeNow, scientists say the woman is the only known carrier of a new blood type called “Gwada negative.” It’s the only blood type ...
Evidence-based recommendations on efgartigimod (Vyvgart) for treating antibody-positive generalised myasthenia gravis in adults.. Last reviewed: 04 June 2025 Next review: This guidance will be ...
Efgartigimod (Vyvgart) is not normally available on the NHS as an add-on to standard treatment for generalised myasthenia gravis in adults who test positive for anti-acetylcholine receptor antibodies.
In this video, Paolo F. Caimi, MD, MBA, discusses research evaluating whether multi-virus specific T-cells could enhance ...
Background: HER2 has been established as an important therapeutic target for BC. IBI354 consists of trastuzumab (anti-HER2 antibody) conjugated to a camptothecin derivative. In a global, multicenter, ...
Background: TQB2930 is a HER2-targeted bispecific antibody designed to bind two distinct HER2 epitopes: the extracellular domain 4 (ECD4), and the extracellular domain 2 (ECD2). In an ongoing phase 1b ...
In patients with an aggressive form of breast cancer, treatment with the antibody-drug conjugate sacituzumab govitecan plus pembrolizumab resulted in durable responses with improved progression ...
IXCHIQ® was well tolerated by children aged one to eleven years regardless of the dose or previous chikungunya infection (CHIKV)Antibody levels remained high after six months in both dose groups, ...
Calicheamicin-conjugated humanized anti-CD33 mouse monoclonal antibody, CMA-676, has recently been introduced to clinics as a promising drug to treat patients with acute myeloid leukemia (AML) in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results